OR WAIT null SECS
September 15, 2022
Brandon Barber, chief marketing officer at Heru, shares about the company's new dark adaptation modality, which they announced during the 2022 Vision Expo West, as well as other advancements in the pipeline.
Janelle Davison, OD, shares highlights from her VEW 2022 presentation, "Intersection of dry eye and beauty: design, build and brand a profitable dry eye spa."
At Vision Expo West 2022, Valerie M. Kattouf, OD, shares her best practices for managing prescription formulas for pediatric patients.
September 14, 2022
Valerie M. Kattouf, OD, shares key highlights and takeaways from her 2022 Vision Expo West presentation titled "Myopia Control."
Jason Compton, OD, shares highlights from his VEW 2022 presentation, "Marketing for specialty lens practice."
With the launch of dark adaptation, Heru is now the only platform on the AMD market to include contrast sensitivity and dark adaptation exams.
September 13, 2022
Those who use oral contraceptives have improved dry eye symptoms, according to research.
September 12, 2022
Low prediction errors from 2 evaluated formulas shows promise for accurate prediction of IOL formulas in high myopic patients.
September 10, 2022
Azura has secured funding to support its 2-stage study evaluating the safety, tolerability, and efficacy of AZR-MD-001, its leading candidate, for patients with contact lens discomfort who show signs of meibomian gland dysfunction.
After a brief hiatus during the pandemic, Orbis' Flying Eye Hospital program returns.
Importance of communication between providers
Unaddressed visual problems negatively impacts safety earnings of workers in underdeveloped countries
What to know about new topical presbyopia-correcting drops
Supplements slow AMD progression, study data confirm
